Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine Pretreatment to Reduce Etomidate-Induced Myoclonus
ChiCTR-IPR-17010340Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dezocine in myoclonus (3 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Mean arterial pressure, Heart rate and 2 more. Started Dec 2016; status: recruiting.
02
Drugs
dezocine
03
Conditions
myoclonus
Beyond the preview
Go deeper on ChiCTR-IPR-17010340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010340.